To improve and simplify the replacement of damaged or severed mitral valve chordae
On-X Life Technologies (On-X LTI) has entered into an exclusive worldwide license with the Cleveland Clinic for a system of products intended to improve and simplify the replacement of damaged or severed mitral valve chordae.
The system is the creation of co-inventors Marc Gillinov, a staff cardiac surgeon at Cleveland Clinic, and Michael Banbury, of Christiana Care’s Center for Heart and Vascular Health, and will be co-developed with the On-X LTI new product development team.
Dr Banbury of Christiana Care’s Center for Heart and Vascular Health, said: “The surgical approach to mitral valve repair appears to be a method by which a long-term satisfactory outcome can be achieved.
“It is our expectation that the surgical tools we will develop with On-X LTI will further enable the surgical approach and enhance the consistency of surgical outcomes, providing patients with the best opportunity for a solution to their mitral incompetence.”
Clyde Baker, president and CEO of On-X LTI, said: “The opportunity for On-X LTI to work with them and to develop this important new surgical system not only enhances the future product offerings of On-X Life Technologies, but also provides us with new insight into the future of heart valve treatment.
“We are extremely pleased to enter into this relationship and expect that surgeons and patients will receive meaningful value from the delivery of these innovative products.”